[ {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A",
    "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ],
    "http://www.nanopub.org/nschema#hasAssertion" : [ {
      "@id" : "http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#assertion"
    } ],
    "http://www.nanopub.org/nschema#hasProvenance" : [ {
      "@id" : "http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#provenance"
    } ],
    "http://www.nanopub.org/nschema#hasPublicationInfo" : [ {
      "@id" : "http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#pubinfo"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#Head"
}, {
  "@graph" : [ {
    "@id" : "http://purl.obolibrary.org/obo/DOID_409",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Disease"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#association",
    "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ {
      "@id" : "http://purl.obolibrary.org/obo/DOID_409"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ {
      "@id" : "https://w3id.org/biolink/vocab/treats"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ {
      "@id" : "https://identifiers.org/drugbank:DB01039"
    } ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "\"Fenoglide is contraindicated in patients with severe renal dysfunction, including those receiving dialysis  [see  Clinical Pharmacology (12.3) Fenoglide is contraindicated in patients with active liver disease, including those with primary biliary cirrhosis and unexplained persistent liver function abnormalities  [see  Warnings and Precautions (5.1) Fenoglide is contraindicated in patients with gallbladder disease  [see  Warnings and Precautions (5.2) Fenoglide is contraindicated in nursing mothers  [see  Use in Specific Populations (8.3) Fenoglide is contraindicated in patients who have a known hypersensitivity to fenofibrate, such as severe skin rashes, including Stevens-Johnson syndrome and toxic epidermal necrolysis.  [see  Warnings and Precautions (5.9)   Severe renal dysfunction, including patients receiving dialysis ( 4 12.3 Active liver disease ( 4 5.1 Gallbladder disease ( 4 5.2 Nursing mothers ( 4 8.3\""
    } ],
    "https://w3id.org/biolink/vocab/provided_by" : [ {
      "@id" : "https://w3id.org/um/NeuroDKG"
    } ],
    "https://w3id.org/biolink/vocab/relation" : [ {
      "@id" : "https://schema.org/MedicalContraindication"
    } ]
  }, {
    "@id" : "https://identifiers.org/drugbank:DB01039",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Drug"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#assertion"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#assertion",
    "http://www.w3.org/ns/prov#wasAttributedTo" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#provenance"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A",
    "http://purl.org/dc/terms/created" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2021-08-22T17:24:55.921+02:00"
    } ],
    "http://purl.org/dc/terms/creator" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate" : [ {
      "@id" : "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate" : [ {
      "@id" : "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ {
      "@id" : "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#sig",
    "http://purl.org/nanopub/x/hasAlgorithm" : [ {
      "@value" : "RSA"
    } ],
    "http://purl.org/nanopub/x/hasPublicKey" : [ {
      "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"
    } ],
    "http://purl.org/nanopub/x/hasSignature" : [ {
      "@value" : "gzpouB/HsT/F/lyzDqXWhW5CLhxMdJPmxEF1OCJv9xXJyMPrF2E1c6a/olTYSsWtFlor8r57KVvu3vltR8+hvF8nALFeR1XdmRVCL2T7F4n4B/aOIWDVLD3LzXs0ZT5eW2yh3OhL+mm6AzO4maw3+8sAC20vVaKjdLVKB4ZEf8U="
    } ],
    "http://purl.org/nanopub/x/hasSignatureTarget" : [ {
      "@id" : "http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#pubinfo"
} ]